Novozymes (NVZMY)
(Delayed Data from OTC)
$63.85 USD
+0.98 (1.56%)
Updated Aug 13, 2024 03:59 PM ET
2-Buy of 5 2
F Value C Growth D Momentum F VGM
Price, Consensus and EPS Surprise
NVZMY 63.85 +0.98(1.56%)
Will NVZMY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NVZMY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NVZMY
ASH vs. NVZMY: Which Stock Should Value Investors Buy Now?
ASH or NVZMY: Which Is the Better Value Stock Right Now?
NVZMY: What are Zacks experts saying now?
Zacks Private Portfolio Services
ASH vs. NVZMY: Which Stock Is the Better Value Option?
MATV vs. NVZMY: Which Stock Should Value Investors Buy Now?
Is CalMaine Foods (CALM) Stock Outpacing Its Basic Materials Peers This Year?
Other News for NVZMY
Givaudan: Current Valuation Offers Unattractive Long-Term Returns
Novonesis price target raised by DKK 20 at Barclays
Chr. Hansen: Outperformance After The Merger And New Novonesis
Kepler Capital Remains a Hold on Novonesis (0Q4U)
Mar Vista Q1 2024 Global Portfolio Strategy Commentary